Sustained inhibition of corneal neovascularization by genetic ablation of CCR5

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 2, 2003, Pages 590-593

  Ambati, Balamurali K ^a,b   Anand, Akshay ^c   Joussen, Antonia M ^b,d   Kuziel, William A ^e   Adamis, Anthony P ^b,f   Ambati, Jayakrishna ^b,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f Eyetech Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD31; BURNS, CHEMICAL; CORNEA; CORNEAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE BURNS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE DELETION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR5; SODIUM HYDROXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037308482     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0685     Document Type: Article

References (34)

1. Epstein RJ, Stulting RD, Hendricks RL, Harris DM. Corneal neovascularization: pathogenesis and inhibition. Cornea. 1987;6:250-257.
2. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
3. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
4. Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol. 1999;65:6-15.
5. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem. 1996;271:17161-17166.
6. Samson M, LaRosa G, Libert F, et al. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem. 1997;272:24934-24941.
7. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
8. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990;85:2004-2008.
9. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
10. Berger O, Gan X, Gujuluva C, et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med. 1999;5:795-805.
11. Moromizato Y, Stechschulte S, Miyamoto K, et al. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol. 2000;157:1277-1281.
12. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522.
13. Pearlman E, Hall LR, Higgins AW, et al. The role of eosinophils and neutrophils in helminth-induced keratitis. Invest Ophthalmol Vis Sci. 1998;39:1176-1182.
14. Chang E, Galle L, Maggs D, Estes DM, Mitchell WJ. Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice. J Virol. 2000;74:11832-11840.
15. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J Virol. 1998;72:3705-3710.
16. Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 1997;278:290-294.
17. Torres PF, De Vos AF, van der Gaag R, Martins B, Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res. 1996;63:453-461.
18. King WJ, Comer PM, Hudde T, Larkin DF, George AJ. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation. 2000;70:1225-1233.
19. Schecter AD, Calderon TM, Berman AB, et al. Human vascular smooth muscle cells possess functional CCR5. J Biol Chem. 2000; 275:5466-5471.
20. Kuziel WA, Maeda N. CCR2 and CCR5. In: Mak TW, ed. The Gene Knockout Facts Book. London: Academic Press; 1998:118-121.
21. Huffnagle GB, McNeil LK, McDonald RA, et al. Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol. 1999;163:4642-4646.
22. Proia AD, Chandler DB, Haynes WL, et al. Quantitation of corneal neovascularization using computerized image analysis. Lab Invest. 1988;58:473-479.
23. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest. 1998;78:1385-1394.
24. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977;269:804-806.
25. Ding Z, He Y, Wei H. A morphological study of experimental corneal neovascularization [in Chinese]. Chung Hua Yen Ko Tsa Chih. 1995;31:49-51.
26. Sonoda K, Sakamoto T, Yoshikawa H, et al. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Invest Ophthalmol Vis Sci. 1998;39:2245-2251.
27. Van der Veen G, Broersma L, Dijkstra CD, Van Rooijen N, Van Rij G, Van der Gaag R. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol Vis Sci. 1994;35:3505-3515.
28. Kaufmann A, Salentin R, Gemsa D, Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1α during differentiation of human monocytes to macrophages. J Leukoc Biol. 2001;69:248-252.
29. Fantuzzi L, Borghi P, Ciolli V, Pavlakis G, Belardelli F, Gessani S. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood. 1999;94:875-883.
30. Tumpey TM, Cheng H, Yan XT, et al. Chemokine synthesis in the HSV-1-infected cornea. J Leukoc Biol. 1998;63:486-492.
31. Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res. 2002;74:293-299.
32. Kernacki KA, Barrett RP, McClellan S, et al. MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection. J Leukoc Biol. 2001; 70:911-919.
33. Hall LR, Diaconu E, Patel R, et al. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J Immunol. 2001;166:4035-4041.
34. Klotz O, Park JK, Pleyer U, et al. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat. Graefes Arch Clin Exp Ophthalmol. 2000;238:88-93.